Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Kolls

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Measurement of TNF and iNOS mRNA using cDNA-equalized reverse transcriptase PCRJ K Kolls, J Xie
Respiratory Research|October 23, 2001
Immune modulation in the treatment of respiratory infectionJ K Kolls, S Nelson
Journal of Molecular Medicine (Berlin, Germany)|February 17, 2009
IL-22: a critical mediator in mucosal host defenseS J Aujla, J K Kolls
Cellular and Molecular Life Sciences : CMLS|February 6, 2003
Retrovirus molecular conjugatesQ Zhong, J K Kolls, P Schwarzenberger
Current Opinion in Molecular Therapeutics|March 16, 2001
Immunotherapy-based treatment strategies for malignant mesotheliomaP Schwarzenberger, P Byrne, J K Kolls
The Journal of Biological Chemistry|April 21, 2001
Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer systemQ Zhong, J K Kolls, P Schwarzenberger
Seminars in Respiratory Infections|April 20, 2001
Gene therapy to modify pulmonary host defensesJ K Kolls, P Ye, J E Shellito
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 4, 2007
Is cystic fibrosis a TH17 disease?P J Dubin, F McAllister, J K Kolls
The American Journal of the Medical Sciences|November 1, 1993
Recombinant cytokines and pulmonary host defenseJ K Kolls, S Nelson, W R Summer
Current Pharmaceutical Design|May 2, 2000
Cytokine therapeutics for infectious diseasesF H Rodriguez, S Nelson, J K Kolls
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Measurement of TNF and iNOS mRNA using cDNA-equalized reverse transcriptase PCRJ K Kolls, J Xie
Respiratory Research|October 23, 2001
Immune modulation in the treatment of respiratory infectionJ K Kolls, S Nelson
Journal of Molecular Medicine (Berlin, Germany)|February 17, 2009
IL-22: a critical mediator in mucosal host defenseS J Aujla, J K Kolls
Cellular and Molecular Life Sciences : CMLS|February 6, 2003
Retrovirus molecular conjugatesQ Zhong, J K Kolls, P Schwarzenberger
Current Opinion in Molecular Therapeutics|March 16, 2001
Immunotherapy-based treatment strategies for malignant mesotheliomaP Schwarzenberger, P Byrne, J K Kolls
The Journal of Biological Chemistry|April 21, 2001
Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer systemQ Zhong, J K Kolls, P Schwarzenberger
Seminars in Respiratory Infections|April 20, 2001
Gene therapy to modify pulmonary host defensesJ K Kolls, P Ye, J E Shellito
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 4, 2007
Is cystic fibrosis a TH17 disease?P J Dubin, F McAllister, J K Kolls
The American Journal of the Medical Sciences|November 1, 1993
Recombinant cytokines and pulmonary host defenseJ K Kolls, S Nelson, W R Summer
Current Pharmaceutical Design|May 2, 2000
Cytokine therapeutics for infectious diseasesF H Rodriguez, S Nelson, J K Kolls
Pageof 7